Analyst Ratings for [ABT] Abbott Laboratories

7/18/25	Upgrades	Hold Buy	X
ABT Abbott Labs Jefferies
$145
6/16/25	Initiated	Market Perform	X
ABT Abbott Labs Leerink Partners
$143
10/8/24	Initiated	Outperform	X
ABT Abbott Labs Oppenheimer
$130
9/19/24	Initiated	Overweight	X
ABT Abbott Labs Piper Sandler
$131
7/30/24	Downgrades	Buy Hold	X
ABT Abbott Labs Edward Jones
5/30/24	Initiated	Buy	X
ABT Abbott Labs Goldman
$121
7/21/23	Upgrades	Underperform Peer Perform	X
ABT Abbott Labs Wolfe Research
5/30/23	Downgrades	Overweight Eq-Weight	X
ABT Abbott Labs Morgan Stanley
$112
4/20/23	Reiterated	Overweight	X
ABT Abbott Labs Barclays
$125 $127
4/20/23	Reiterated	Outperform	X
ABT Abbott Labs Bernstein
$132 $133
4/20/23	Reiterated	Overweight	X
ABT Abbott Labs JP Morgan
$118 $122
4/20/23	Reiterated	Outperform	X
ABT Abbott Labs Raymond James
$116 $123
4/20/23	Reiterated	Buy	X
ABT Abbott Labs UBS
$117 $130
4/20/23	Reiterated	Underperform	X
ABT Abbott Labs Wolfe Research
$107 $103
3/29/23	Initiated	Buy	X
ABT Abbott Labs UBS
$117
10/26/22	Initiated	Neutral	X
ABT Abbott Labs Mizuho
$105
10/18/22	Initiated	Overweight	X
ABT Abbott Labs Barclays
$118
10/12/22	Initiated	Hold	X
ABT Abbott Labs Jefferies
$110
7/6/22	Initiated	Underperform	X
ABT Abbott Labs Wolfe Research
$95
1/27/22	Reiterated	Outperform	X
ABT Abbott Labs Credit Suisse
$138 $139
1/27/22	Reiterated	Overweight	X
ABT Abbott Labs Morgan Stanley
$157 $151
1/27/22	Reiterated	Outperform	X
ABT Abbott Labs Raymond James
$150 $143
1/27/22	Reiterated	Buy	X
ABT Abbott Labs UBS
$138 $142
12/10/21	Initiated	Outperform	X
ABT Abbott Labs RBC Capital Mkts
$146
10/27/21	Upgrades	Neutral Overweight	X
ABT Abbott Labs Atlantic Equities
$144
10/14/21	Initiated	Neutral	X
ABT Abbott Labs Redburn
5/25/21	Initiated	Overweight	X
ABT Abbott Labs Barclays
$150
4/15/21	Initiated	Neutral	X
ABT Abbott Labs Atlantic Equities
$122
1/28/21	Upgrades	Neutral Buy	X
ABT Abbott Labs BTIG Research
$140
6/13/19	Reiterated	Buy	X
ABT Abbott Labs BofA/Merrill
$81 $90
2/7/19	Reiterated	Buy	X
ABT Abbott Labs BofA/Merrill
$73 $81
1/2/19	Downgrades	Neutral Sell	X
ABT Abbott Labs Citigroup
11/30/18	Upgrades	Neutral Buy	X
ABT Abbott Labs Goldman
10/16/18	Initiated	Overweight	X
ABT Abbott Labs Barclays
$80
6/27/18	Initiated	Outperform	X
ABT Abbott Labs Bernstein
$73
1/30/18	Reiterated	Neutral	X
ABT Abbott Labs Citigroup
$59 $64

ABT Abbott Laboratories

Quotes: Barrons • SeekingAlpha • NASDAQ • Bloomberg • WSJ

Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the United States. Its Diagnostic Products include a range of diagnostic systems and tests. Its Nutritional Products include a range of pediatric and adult nutritional products. Its Company's Vascular Products include a range of coronary, endovascular, vessel closure and structural heart devices for the treatment of vascular disease. The Company, through St. Jude Medical, Inc., also offers products, such as rhythm management products, electrophysiology products, heart failure related products, vascular products, structural heart products and neuromodulation products.